{"id":"lnth-2403","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T06:12:29.195Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T09:28:24.640655+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07272642","phase":"PHASE1","title":"A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.","status":"NOT_YET_RECRUITING","sponsor":"Radiopharm Theranostics, Ltd","startDate":"2026-01-30","conditions":"Imaging, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma","enrollment":16},{"nctId":"NCT07357519","phase":"PHASE1, PHASE2","title":"Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)","status":"RECRUITING","sponsor":"Lantheus Medical Imaging","startDate":"2026-02","conditions":"Relapsed / Refractory Osteosarcoma","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"LNTH-2403","genericName":"LNTH-2403","companyName":"Radiopharm Theranostics, Ltd","companyId":"radiopharm-theranostics-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T09:28:24.640655+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}